Table 5 Indicators of interactions with pharmaceutical companies analysed by country.
From: Advertising and disclosure of funding on patient organisation websites: a cross-sectional survey
Country & no. of patient organisation websites | Proportion of income from Pharma is clear | Use of Pharma funding is clear | Clear that Pharma funding is 'unrestricted' | Pharma logos are present | Pharma introductions present | Evidence of Pharma sponsored events, etc. | Links to Pharma websites present |
|---|---|---|---|---|---|---|---|
Australia (n = 11) | 0 | 0 | 2 | 4 | 1 | 1 | 3 |
Canada (n = 12) | 0 | 2 | 1 | 7 | 3 | 2 | 6 |
S. Africa (n = 7) | 0 | 0 | 0 | 3 | 0 | 0 | 2 |
UK (n = 15) | 0 | 3 | 2 | 5 | 1 | 2 | 4 |
USA (n = 16) | 0 | 5 | 3 | 2 | 2 | 5 | 5 |
Global (n = 8) | 0 | 1 | 1 | 2 | 0 | 2 | 1 |
Total (n = 69) n [%] | 1 [1%] | 11 [16%] | 9 [13%] | 23 [33%] | 7 [10%] | 12 [17%] | 21 [30%] |